Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 86 of 114, showing 5 Applications out of 570 total, starting on record 426, ending on 430

# Protocol No Study Title Investigator(s) & Site(s)

426.

ECCT/17/03/01   The POWER cohort
    A cohort for evaluation of open-label PrEP delivery among Kenyan and South African women   
Principal Investigator(s)
1. Dr. Stella Njuguna
Site(s) in Kenya
1. Jaramogi Oginga Odinga Teaching and Referral Hospital. (Kisumu county)
 
View

427.

ECCT/16/12/03   The Partners Scale-Up Project
    An implementation project to scale-up delivery of antiretroviral-based HIV-1 prevention among Kenyan HIV-1 serodiscordant couples   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
1. Thika Level 5 Hospital, Ruiru Sub-County Hospital, Kiambu County Hospital, Kikuyu PCEA Hospital (Kiambu county)
2. Coptic Hospital, Mbagathi Hospital, St. Mary\'s Hospital, Pumwani Maternity Hospital (Nairobi City county)
3. Nyeri PGH, Karatina Sub-County Hospital, (Nyeri county)
4. Kerugoya County Hospital (Kirinyaga county)
5. Murang\'a County Hospital (Murang\'a county)
 
View

428.

ECCT/16/12/02   Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis:
    Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: A randomized, open-label, controlled phase 3 clinical trial.   
Principal Investigator(s)
1. ISAAC TSIKHUTSU
Site(s) in Kenya
KEMRI/WRP, KERICHO
 
View

429.

ECCT/16/12/01   The Partners Scale-Up Project
    Animplementation project to scale-up delivery of antiretroviral-based HIV-1 prevention amongKenyan HIV-1 serodiscordant couples.   
Principal Investigator(s)
1. Prof. Elizabeth Ann Bukusi
Site(s) in Kenya
1. KISUMU SITE (Kisumu county)
2. Thika Site (Kiambu county)
 
View

430.

ECCT/16/11/05   RV 456: Vaccines for Ebola Ad26.ZEBOV and MVA-BN-Filo
    A randomized, obsever-blind, placebo controlled, two-part, Phase 2 study to evaluate the Safety, Tolerability and Immunogenicity of Two prime-boost regimen of the candidate Prophylactic vaccines for Ebola Ad26-ZEBOV and MVA-BN Filo.   
Principal Investigator(s)
1. Fredrick Kipyego Sawe
Site(s) in Kenya
1. KEMRI/WRP Kericho (Kericho county)
2. KEMRI/WRP Kombewa, Kisumu (Kisumu county)
 
View